Search Within

Jedd D Wolchok

  1. "Massachusetts Medical Society"
Formats
  1. Journal Article (22)
Groups
  1. Department of Medicine (22)
  2. GSK Faculty (22)
  3. Melanoma and Immunotherapeutics Service (22)
  4. Solid Tumor Oncology Division (22)
  5. Melanoma Disease Management Team (7)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)

More Groups

People
  1. Margaret Callahan (7)
  2. Michael Postow (7)
  3. Alexandra Snyder Charen (3)
  4. Taha Merghoub (3)
  5. Timothy Chan (3)
  6. Alexander Lesokhin (2)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (3)
  4. 2016 (1)
  5. 2015 (6)
  6. 2014 (1)

More Years

Publications
  1. New England Journal of Medicine (22)
Publishers
  1. Massachusetts Medical Society (22)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five-year survival with combined nivolumab and ipilimumab in advanced melanoma
    Journal Article

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Neoadjuvant PD-1 blockade in resectable lung cancer
    Journal Article

    Forde, P. M.; Chaft, J. E.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Hellmann, M. D.; Zahurak, M.; Yang, S. C.; Jones, D. R.; Broderick, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • The authors reply
    Journal Article

    Wolchok, J. D.; Rollin, L.; Larkin, J.
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • The authors reply
    Journal Article

    Wolchok, J. D.; Rollin, L.; Larkin, J.
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • Overall survival with combined nivolumab and ipilimumab in advanced melanoma
    Journal Article

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Schadendorf, D.; Ferrucci, P. F.; more...
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy
    Journal Article

    Eggermont, A. M. M.; Chiarion-sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; more...
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • Correction: Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Journal Article

    Chan, T. A.; Wolchok, J. D.; Snyder, A.
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Combined nivolumab and ipilimumab or monotherapy in untreated melanoma - Reply
    Journal Article

    Larkin, J.; Hodi, F. S.; Wolchok, J. D.
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
    Journal Article

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Dummer, R.; Smylie, M.; Rutkowski, P.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Rapid eradication of a bulky melanoma mass with one dose of immunotherapy
    Journal Article

    Chapman, P. B.; D'Angelo, S. P.; Wolchok, J. D.
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save